ACRO Biomedical obtained China patent, "Preparation of high purity collagen particles and uses thereof" on January 14th. ACRO will enter China's large and fast-growing aesthetic medicine and micro-plastic surgery market with this patent. Other than the China patent, ACRO has obtained the same patent from Taiwan, South Korea, Japan, and the USA.

The trend of micro-plastic surgery in aesthetic medicine has driven the demand for collagen and hyaluronic acid implants in recent years and has accelerated the growth of the aesthetic medicine market. ACRO Biomedical utilizes the patented technology of natural collagen scaffold particles on aesthetic medicine, aiming at the field of anti-aging and skin regeneration medical field. The company said that although there are many competitors in the market for collagen-based products, there are more benefits in using "supercritical carbon dioxide (ScCO2)" during the production process. The process is simple, and the cost is low. It is also environmental friendly since there is no need to add chemical cross-linking agents, which can carcinogens, during the process.

Founded in 2014, ACRO Biomedical focuses on the research, development and production of high-end medical materials related to human tissue engineering and repairing. The company uses supercritical carbon dioxide (ScCO2) extraction technology to to remove cells, fat, and non-collagenous proteins from animal tissues and organs, while leaving the intact collagen scaffolds as the biomaterial for high-end medical devices in the field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular, and neural surgery, etc.

The global tissue engineering market is expected to reach US$6.16 billion in 2021, with a compound annual growth rate of 27.9% from 2017 to 2021. It is estimated that the size of Taiwan's regenerative medicine market will reach NT$4 billion in 2024.

ACRO Biomedical develops and produces biomedical materials by utilizing the supercritical carbon dioxide (ScCO2) technology platform. This ScCO2 process is used for biological tissue cleaning and extraction, which can perform extraction, cleaning, separation, and bacteria reduction in one single step. It can maintain the bioactivity of the tissue without destroying the original properties of the material during the production process. It can also help to remove residual chemicals from other processes.